Inactive Instrument

News Applied DNA Sciences Inc OTC Bulletin Board

Equities

APDN

US03815U1025

End-of-day quote OTC Bulletin Board Other stock markets
-	-

Apr. 03	Certain Warrants of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.	CI
Apr. 03	Certain Options of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Certain Warrants of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.	Apr. 02	CI
Certain Options of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.	Apr. 02	CI
Certain Common Stock of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.	Apr. 02	CI
Applied DNA to Showcase Linea DNA and Linea IVT Platforms at 24th Annual World Vaccine Congress	Mar. 15	AQ
Applied DNA Sciences, Inc. to Showcase Linea DNA and Linea IVT Platforms At 24Th Annual World Vaccine Congress	Mar. 14	CI
Applied DNA Sciences Files Prospectus for Potential Secondary Stock Offerings	Mar. 12	MT
Applied DNA Sciences: Fiscal Q1 Earnings Snapshot	Feb. 08	AQ
Transcript : Applied DNA Sciences, Inc., Q1 2024 Earnings Call, Feb 08, 2024	Feb. 08
Earnings Flash (APDN) APPLIED DNA SCIENCES Reports Q1 Revenue $891,164	Feb. 08	MT
Applied DNA Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 08	CI
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules	Feb. 01	AQ
Applied DNA Announces Joint Development Agreement to Integrate Linea IVT Platform into CDMO Kudo Biotechnology's mRNA Manufacturing Workflow	Dec. 15	AQ
Applied DNA Sciences, Inc. Announces Joint Development Agreement to Integrate Linea IVT Platform into CDMO Kudo Biotechnology?s mRNA Manufacturing Workflow	Dec. 14	CI
HC Wainwright Cuts Price Target on Applied DNA Sciences to $2 From $4, Keeps Buy Rating	Dec. 08	MT
Applied DNA Sciences: Fiscal Q4 Earnings Snapshot	Dec. 07	AQ
Transcript : Applied DNA Sciences, Inc., Q4 2023 Earnings Call, Dec 07, 2023	Dec. 07
Earnings Flash (APDN) APPLIED DNA SCIENCES Posts Q4 Revenue $779,736, vs. Street Est of $1.7M	Dec. 07	MT
Applied DNA Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	Dec. 07	CI
Applied DNA Sciences, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	Dec. 07	CI
Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023	Dec. 06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Applied DNA Sciences Inc OTC Bulletin Board

Equities

APDN

US03815U1025

Summary

Filters